NCT03706924 Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03706911 Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03706898 Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs Status COMPLETED Phase PHASE1
NCT03646370 Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen Status COMPLETED Phase N/A
NCT03624413 InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media Status COMPLETED Phase NA
NCT03589027 Darunavir and Rilpivirine Interactions With Levonorgestrel Implant Status UNKNOWN Phase PHASE2
NCT03580668 Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide Status COMPLETED Phase N/A
NCT03570918 MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy Status COMPLETED Phase PHASE1
NCT03567304 Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine Status UNKNOWN Phase PHASE4
NCT03549689 Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) Status WITHDRAWN Phase PHASE2
NCT03549312 Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy Status UNKNOWN Phase PHASE4
NCT03539224 Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept. Status UNKNOWN Phase PHASE2
NCT03536234 Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients Status UNKNOWN Phase PHASE2
NCT03532425 B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults Status TERMINATED Phase PHASE4